Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?
about
Predicting short-term survival after liver transplantation on eight score systems: a national report from China Liver Transplant Registry.Diuretic usage for protection against end-organ damage in liver cirrhosis and heart failure.Ten pitfalls in the proper management of patients with hyponatremia.Treatment for cirrhotic ascites.Predictive parameter of tolvaptan effectiveness in cirrhotic ascites.Water, electrolyte, acid-base, and trace elements alterations in cirrhotic patients.Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma.Hyponatremia in the elderly: challenges and solutions.Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM).Management of refractory cirrhotic ascites: challenges and solutions
P2860
Q37638019-2103BEDA-F481-432F-B300-ED8E72F14120Q38779628-6A423CC8-2FA2-48A5-906D-FB397DADBD85Q38827652-019F21C6-240A-48E6-91A1-4C22219E8073Q38882366-9971DB63-F13F-4797-865D-490C6C089CDBQ39321625-9443960F-15EF-481B-8FCF-FA8B11080DA6Q39368656-9BA40E05-1C63-44DA-8102-F5A2A6F9B81EQ41334703-A47F08F0-B498-478F-8FA0-5B3B9EBFAEDAQ46064949-47706345-1476-40EB-A5FF-A7127994530AQ49893436-6E12D928-BEB8-402B-A2E1-7465E8AFB3A4Q57407557-6A719EB9-EAA4-48B3-A78B-05610908766C
P2860
Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?
@ast
Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?
@en
Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?
@nl
type
label
Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?
@ast
Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?
@en
Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?
@nl
prefLabel
Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?
@ast
Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?
@en
Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?
@nl
P2860
P1476
Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?
@en
P2093
Hiroshi Fukui
P2860
P304
P356
10.3748/WJG.V21.I41.11584
P407
P577
2015-11-07T00:00:00Z